(Q86706145)
Statements
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial (English)
Eliot A Brinton
Uma Kher
Sukrut Shah
Christopher P Cannon
Michael Davidson
Antonio M Gotto
Tanya B Ashraf
Christine McCrary Sisk
Hayes Dansky
Yale Mitchel
Philip Barter
DEFINE Investigators
4 November 2014